PDF (Author version) 133289 - Sex di...pdf | Document not available for request/download Full text restricted until 19 January 2020.

Abstract

In this review, we describe the sex differences in prevalence, onset, symptom profiles and disease outcome that are evident in schizophrenia, bipolar disorder and post-traumatic stress disorder. Women with schizophrenia tend to exhibit less disease impairment than men; by contrast, women with post-traumatic stress disorder are more affected than men. The most likely candidates to explain these sex differences are gonadal hormones. This review details the clinical evidence that estradiol and progesterone are dysregulated in these psychiatric disorders. Notably, existing data on estradiol, and to a lesser extent, progesterone, suggest that low levels of these hormones may increase the risk of disease development and worsen symptom severity. We argue that future studies require a more inclusive, considered analysis of gonadal steroid hormones and the intricacies of the interactions between them, with methodological rigour applied, to enhance our understanding of the roles of steroid hormones in psychiatric disorders.

Item Type:	Article
Authors/Creators:	Gogos, A and Ney, LJ and Seymour, N and Van Rheenen, TE and Felmingham, KL
Keywords:	schizophrenia, bipolar disorder (BD), posttraumatic stress disorder (PTSD), estradiol; progesterone, sex differences, sex hormones
Journal or Publication Title:	British Journal of Pharmacology
Publisher:	John Wiley & Sons Ltd.
ISSN:	1476-5381
DOI / ID Number:	10.1111/bph.14584
Copyright Information:	Copyright 2019 The British Pharmacological Society. This is the pre-peer reviewed version of the article, which has been published in final form at http://dx.doi.org/10.1111/bph.14584. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
Item Statistics:	View statistics for this item

Actions (login required)

Item Control Page